Single Dose Pharmacokinetics of Intravenous Tedizolid Phosphate in Morbidly Obese and Age-, Sex-, and Ideal Body Weight-Matched Non-Obese Adults

Trial Profile

Single Dose Pharmacokinetics of Intravenous Tedizolid Phosphate in Morbidly Obese and Age-, Sex-, and Ideal Body Weight-Matched Non-Obese Adults

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Mar 2017

At a glance

  • Drugs Tedizolid (Primary)
  • Indications Bacteraemia; Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 May 2016 Results published in the Antimicrobial Agents and Chemotherapy
    • 02 Feb 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top